Samil Pharmaceutical Co (XKRX:000520) Construction In Progress : ₩136,020 Mil (As of Mar. 2024)

View and export this data going back to 1985. Start your Free Trial

What is Samil Pharmaceutical Co Construction In Progress?

Samil Pharmaceutical Co's quarterly construction in progress declined from Sep. 2023 (₩132,895 Mil) to Dec. 2023 (₩132,199 Mil) but then increased from Dec. 2023 (₩132,199 Mil) to Mar. 2024 (₩136,020 Mil).

Samil Pharmaceutical Co's annual construction in progress increased from Dec. 2021 (₩55,341 Mil) to Dec. 2022 (₩120,009 Mil) and increased from Dec. 2022 (₩120,009 Mil) to Dec. 2023 (₩132,199 Mil).

Samil Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Samil Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samil Pharmaceutical Co Construction In Progress Chart

Samil Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

12,050.44

22,791.56

55,341.20

120,008.59

132,198.63

Samil Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															126,606.77	128,774.22	132,894.94	132,198.63	136,019.82

Samil Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Samil Pharmaceutical Co (XKRX:000520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samil Pharmaceutical Co Ltd (XKRX:000520) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

990-1, Bangbae-dong, Seocho-Gu, Seoul, KOR, 137-060

Website

http://www.samil-pharm.co.kr

Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.

Samil Pharmaceutical Co (XKRX:000520) Headlines

No Headlines